PowerUp Acquisition (PWUP) Competitors $11.50 +0.07 (+0.61%) (As of 12/20/2024 04:30 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PWUP vs. VYGR, CTNM, BTMD, SLRN, KMDA, CGC, ETON, AQST, SAGE, and TRVIShould you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include Voyager Therapeutics (VYGR), Contineum Therapeutics (CTNM), biote (BTMD), Acelyrin (SLRN), Kamada (KMDA), Canopy Growth (CGC), Eton Pharmaceuticals (ETON), Aquestive Therapeutics (AQST), Sage Therapeutics (SAGE), and Trevi Therapeutics (TRVI). These companies are all part of the "pharmaceutical products" industry. PowerUp Acquisition vs. Voyager Therapeutics Contineum Therapeutics biote Acelyrin Kamada Canopy Growth Eton Pharmaceuticals Aquestive Therapeutics Sage Therapeutics Trevi Therapeutics PowerUp Acquisition (NASDAQ:PWUP) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap unclassified companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends. Which has more risk and volatility, PWUP or VYGR? PowerUp Acquisition has a beta of 0.02, suggesting that its stock price is 98% less volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500. Do analysts prefer PWUP or VYGR? Voyager Therapeutics has a consensus target price of $17.00, indicating a potential upside of 195.65%. Given Voyager Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Voyager Therapeutics is more favorable than PowerUp Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PowerUp Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Voyager Therapeutics 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.11 Do insiders and institutionals hold more shares of PWUP or VYGR? 19.2% of PowerUp Acquisition shares are owned by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are owned by institutional investors. 48.0% of PowerUp Acquisition shares are owned by insiders. Comparatively, 4.5% of Voyager Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has better earnings & valuation, PWUP or VYGR? Voyager Therapeutics has higher revenue and earnings than PowerUp Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPowerUp AcquisitionN/AN/AN/AN/AN/AVoyager Therapeutics$163.78M1.92$132.33M$0.718.10 Does the MarketBeat Community prefer PWUP or VYGR? Voyager Therapeutics received 392 more outperform votes than PowerUp Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformPowerUp AcquisitionN/AN/AVoyager TherapeuticsOutperform Votes39267.59% Underperform Votes18832.41% Is PWUP or VYGR more profitable? Voyager Therapeutics has a net margin of 15.80% compared to PowerUp Acquisition's net margin of 0.00%. Voyager Therapeutics' return on equity of 8.33% beat PowerUp Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets PowerUp AcquisitionN/A N/A N/A Voyager Therapeutics 15.80%8.33%6.15% Does the media prefer PWUP or VYGR? In the previous week, Voyager Therapeutics had 3 more articles in the media than PowerUp Acquisition. MarketBeat recorded 3 mentions for Voyager Therapeutics and 0 mentions for PowerUp Acquisition. Voyager Therapeutics' average media sentiment score of 0.50 beat PowerUp Acquisition's score of 0.00 indicating that Voyager Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment PowerUp Acquisition Neutral Voyager Therapeutics Neutral SummaryVoyager Therapeutics beats PowerUp Acquisition on 13 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get PowerUp Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PWUP vs. The Competition Export to ExcelMetricPowerUp AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$89.30M$422.11M$118.84M$9.08BDividend YieldN/A6.38%5.20%4.23%P/E RatioN/A2.511.5317.18Price / SalesN/A129.081.33116.99Price / CashN/A61.1578.6637.86Price / BookN/A84.22519.874.78Net IncomeN/A$33.84M$2.37M$225.60M7 Day PerformanceN/A9.49%0.37%-1.23%1 Month PerformanceN/A44.43%46.10%3.36%1 Year Performance1.59%26.66%23.45%16.60% PowerUp Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PWUPPowerUp AcquisitionN/A$11.50+0.6%N/A+5.7%$89.30MN/A0.00N/AVYGRVoyager Therapeutics4.6114 of 5 stars$6.48+3.3%$17.00+162.3%-27.6%$354.00M$250.01M8.83100CTNMContineum Therapeutics1.9558 of 5 stars$13.66-2.6%$29.25+114.1%N/A$352.13M$50M0.0031News CoverageHigh Trading VolumeBTMDbiote3.0893 of 5 stars$6.39+0.3%$9.11+42.6%+20.8%$347.21M$193.06M24.77194Positive NewsGap UpSLRNAcelyrin2.7884 of 5 stars$3.37+4.3%$11.75+248.7%-55.8%$338.11MN/A-1.31135KMDAKamada3.8909 of 5 stars$5.80-1.2%$14.50+150.0%-1.2%$333.38M$158.38M20.96360Positive NewsCGCCanopy Growth2.4368 of 5 stars$3.04-2.3%$3.50+15.1%-41.0%$331.18M$220.27M-0.621,029Analyst RevisionNews CoverageETONEton Pharmaceuticals2.1328 of 5 stars$12.74+3.2%$15.00+17.7%+176.9%$329.20M$31.64M-57.9120High Trading VolumeAQSTAquestive Therapeutics1.495 of 5 stars$3.60-0.3%$9.80+172.2%+95.2%$328.25M$50.58M-8.00160Analyst ForecastAnalyst RevisionNews CoveragePositive NewsSAGESage Therapeutics4.1504 of 5 stars$5.34-0.9%$11.53+115.9%-73.1%$326.66M$106.40M-0.96690TRVITrevi Therapeutics3.0363 of 5 stars$4.24+1.7%$9.31+119.6%+214.0%$325.93MN/A-9.6420Gap DownHigh Trading Volume Related Companies and Tools Related Companies VYGR Competitors CTNM Competitors BTMD Competitors SLRN Competitors KMDA Competitors CGC Competitors ETON Competitors AQST Competitors SAGE Competitors TRVI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PWUP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PowerUp Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share PowerUp Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
